Navigation Links
ScandiDos Sells 100th Delta4(R) PT Unit as Adoption of Rotational Therapy Cancer Treatment Increases
Date:11/3/2009

is independent gantry angle verification, and, as such, accounts for this area of potential discrepancy as part of its measurement.

"We are very pleased that Advocate Lutheran General Hospital has chosen Delta4 PT as part of the technology solution to offer advanced radiation treatments to its patients," says Brad Dugai, National Sales Manager at ScandiDos.

"When we installed our first Delta4 in 2006, it was used to verify both IMRT and Arc Therapy treatments. Now, 3 years later, rotational therapy is becoming the new standard radiation therapy and, significantly, our 100th installed system will be used for both TomoTherapy and Varian RapidArc," says Ingemar Wiberg, VP of Sales and Marketing at ScandiDos.

Delta4 has been used by linear accelerator manufacturers in the development and validation of arc therapy treatment modalities to include Varian's RapidArc and Elekta's VMAT solution.

About ScandiDos

ScandiDos is the innovative company that introduced the new QA standard in advanced radiotherapy by moving into the era of 3D and 4D volumetric dosimetry. Founded in 2002 by a group of highly experienced physicists and engineers, ScandiDos grew out of a recognized need for practical clinical solutions for new advanced radiation therapy technologies. ScandiDos mission is to provide complete dosimetry solutions that enable clinics around the world to implement new treatment modalities satisfying the demand on accuracy in dose verification and patient through-put. ScandiDos has offices in Uppsala, Sweden and Richmond, VA, USA and is a privately held company. For more information visit www.scandidos.com

For more information, please contact:

Ingemar Wiberg, Vice President of Sales and Marketing, ScandiDos, Inc.

+46 18 472 30 31, email: '/>"/>

SOURCE ScandiDos
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY
2. Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System
3. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
4. Adoption of PCI in AMI Patients to Drive Drug-Eluting Stent Use
5. Frost & Sullivan Identifies Focus on Quality Management and Adoption of a Full-service Model as Keys to the Growth of the European CRO Market
6. GHX Health ConneXion(TM) Data Pool Gains Momentum as Healthcare Industry Moves Toward Standards Adoption
7. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
8. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
9. Progesterone Therapy and Preterm Birth: More Evidence Helps Identify Women Who Can Benefit
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Diamyd Updates Gene Therapy Program and Outlines Plans for Phase I Clinical Trial for Treatment of Cancer Pain

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., TAMPA, Fla., Dec. 2 Laser Spin...ve spinal surgery, is pleased to announce a partn...r an extensive six-month negotiation and clinical ...st healthcare provider of minimally invasive spina... Effective immediately, patients with United Healt...
(Date:12/2/2009)... , LAKE FOREST, Ill., Dec. 2 /PRNewswire-Firs...provider of clinical information and medication de...cquired Salt Lake City-based TheraDoc, a clinical ...lance systems. TheraDoc,s two leading products, In...tant(TM), join Hospira,s expanding portfolio of me...
(Date:12/2/2009)..., WALTHAM, Mass. and NEW YORK, Dec. 2 /PRNewswi...Amex: ILI ) and NYU Langone Medical Center announ...on with Duke University on the genetics of osteoar...ne First" version of the Annals of Rheumatic Disea...pidpdf/ard.2009.113043v1.pdf . Results from th...
Breaking Medicine Technology:Laser Spine Institute Partners with United Healthcare 2Laser Spine Institute Partners with United Healthcare 3Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 2Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 3Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 4Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 5Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 2Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 3Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 4Young Ballerinas May Face Heart Bone Risks 47452 1Isis Highlights New Clinical Data on Anti Cancer Antisense Drugs Featured at ASCO 47448 1Isis Highlights New Clinical Data on Anti Cancer Antisense Drugs Featured at ASCO 47448 2Isis Highlights New Clinical Data on Anti Cancer Antisense Drugs Featured at ASCO 47448 3Isis Highlights New Clinical Data on Anti Cancer Antisense Drugs Featured at ASCO 47448 4Millennium Research Groups New Perception Pulse Product Offers Clients an Innovative New Customer Behavior and Loyalty Tracking Tool 47444 1Millennium Research Groups New Perception Pulse Product Offers Clients an Innovative New Customer Behavior and Loyalty Tracking Tool 47444 2Millennium Research Groups New Perception Pulse Product Offers Clients an Innovative New Customer Behavior and Loyalty Tracking Tool 47444 3
...nual Meeting of the American Society of,Clinical O...SciClone Pharmaceuticals,Inc. (Nasdaq:SCLN) and S...d product candidate thymalfasin (ZADAXIN(r), thymo...ase 2 clinical trial,treating patients diagnosed w... form of skin cancer. Results showed that thymalfa...
...4, 2007 /PRNewswire-FirstCall/ -- Kosan,Bioscience...hase 2,monotherapy trial showing that tanespimycin...in patients with metastatic melanoma,including on...led,prior chemotherapy (within 6 weeks of initiati...sion-free survival for more than,six months and 20...
Other Medicine Technology:Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity,of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO 2Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity,of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO 3Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity,of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO 4
(Date:12/2/2009)...in 90 minutes of hospital arrival, study finds , ... nationwide program to get faster treatment for pe... dramatically reduced the time between hospital ar...hree-quarters of people with STEMI heart attacks -...rn that shows major blockage of a heart artery -- ...
(Date:12/2/2009)...tabolic syndrome, study finds , , WEDNES...,t enough to keep overweight college football play...ion that can lead to heart disease, a new study su...on I colleges and found that two-thirds were obese...roup of conditions that raise the risk for heart d...
(Date:12/2/2009)... Huntington Memorial Hos...of Approval from the Joint Commission, designating... Huntington will join the network of "approved str...y. ,, "This is a significant milestone for th...t for Pasadena and its surrounding communities," s...
(Date:12/2/2009).... 2 Researchers from ar...d cancer research at the annual American Society o...ber 4-8, 2009. ,, Throughout the ASH conferenc...ts, including Chief Medical Officer Barton Kamen, ...ices Hildy Dillon, and Vice President, Research Co...
(Date:12/2/2009)...ec. 2 Care Support of America,s ... Advanced Illness Coordinated Care (AICC) , has be...ars of life as well as improve the quality of life...ncreasing mortality. These are the principal findi...of Managed Care (November 2009). ,, Based ...
Breaking Medicine News(10 mins):Health News:Heart Attack Treatment Speeds Up Nationwide 2Health News:Heart Attack Treatment Speeds Up Nationwide 3Health News:Oversized College Football Players May Face Heart Risks 2Health News:Huntington Hospital Earns Designation as Primary Stroke Center 2Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 2Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 3Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 4
...eggy Fleming, Bruce Jenner, Jackie Joyner-Kersee, ... the Importance of Specialized .... 16 In years past,each has battled for Olympic g...ic gold medal athletes and,Medco Health Solutions,...
...ended by the College of Chest Physicians for Lung ...ORONTO, Oct. 16 /PRNewswire-FirstCall/ - Novadaq(R...l-time medical imaging systems and image,guided th...ge of Chest Physicians (ACCP), CHEST 2007, to be h...
...f., Oct. 16 When you are healthy,purchasing disab...sing,disability insurance protects your most preci..., says Frank N. Darras, the nation,s leading,disab...nsive, you want to make sure you,buy the right typ...
...Oct. 16 Many people know that you can use,your he...ut it can be used,in other ways, too. "Your heart ...rdiovascular system," says Stan Reents, PharmD, a ...ge into a simple formula, people can determine the...
... Md., Oct. 16 Introducing Wordsies(TM) for,babies...es specially,created for babies and toddlers that ...rld. Wordsies(TM) was created by a mother of three..., http://www.prnewswire.com/mnr/wordsies/30190/ ...
...ales Executive to Lead Growing Medical Device Firm...Inc., a,leading provider of innovative medical dev...lar surgeons for the minimally invasive treatment ...hief,Executive Officer. Mr. Cramer joined Bacchus...
Other Medicine News:Health News:Six Olympic Legends Battling Chronic Diseases Lead Revolution in Advancing Pharmacy Care as Medco Launches the 'Tour of Champions' 2Health News:Six Olympic Legends Battling Chronic Diseases Lead Revolution in Advancing Pharmacy Care as Medco Launches the 'Tour of Champions' 3Health News:Six Olympic Legends Battling Chronic Diseases Lead Revolution in Advancing Pharmacy Care as Medco Launches the 'Tour of Champions' 4Health News:Six Olympic Legends Battling Chronic Diseases Lead Revolution in Advancing Pharmacy Care as Medco Launches the 'Tour of Champions' 5Health News:Novadaq launches PINPOINT: Company's first minimally invasive imaging system 2Health News:Novadaq launches PINPOINT: Company's first minimally invasive imaging system 3Health News:Novadaq launches PINPOINT: Company's first minimally invasive imaging system 4Health News:Why Healthy People Should Consider Individual Disability Insurance 2Health News:Exercise And Health: Use Your Heart Rate As a Guide 2Health News:Photo: Introducing a New Line of Baby and Toddler Shirts that Can Help Protect Innocent Babies During Flu Season 2Health News:Bacchus Vascular Names Scott Cramer as President and CEO 2
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
Medicine Products: